Cynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells

MT Newswires Live

05/29

Cynata Therapeutics (ASX:CYP) said the World Health Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.

The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.

The generic name represents the active agent in iPSC-derived MSC products.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2639612707"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2639612707\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2639612707?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 08:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639612707","market":"sg","top_or_hot":-1,"title":"Cynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/CYP.AU\">Cynata Therapeutics</a> (ASX:CYP) said the <a href=\"https://laohu8.com/S/WHEN\">World Health</a> Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.</p><p>The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.</p><p>The generic name represents the active agent in iPSC-derived <a href=\"https://laohu8.com/S/NPW.SI\">MSC</a> products.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-29 08:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/CYP.AU\">Cynata Therapeutics</a> (ASX:CYP) said the <a href=\"https://laohu8.com/S/WHEN\">World Health</a> Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.</p><p>The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.</p><p>The generic name represents the active agent in iPSC-derived <a href=\"https://laohu8.com/S/NPW.SI\">MSC</a> products.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYP.AU","symbol_name":"CYNATA THERAPEUTICS LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2639612707","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2639612707","pubTimestamp":1780013828,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cynata Therapeutics  said the World Health Organization  selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell -derived mesenchymal stem cells , according to a Friday Australian bourse filing.The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.The generic name represents the active agent in iPSC-derived MSC products.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CYP.AU":"CYNATA THERAPEUTICS LTD","BK7067":"生物科技","BK7508":"医药生物股","BK4575":"芯片概念","BK7501":"新冠治疗股","MSC":"新濠影汇","BK4150":"赌场与赌博"},"translate_title":"Cynata表示世卫组织为Cymerus间充质干细胞选择通用名","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MSC":1,"CYP.AU":1},"content_text":"Cynata Therapeutics (ASX:CYP) said the World Health Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.The generic name represents the active agent in iPSC-derived MSC products.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}